Simplex Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-163,400
| Closed | -$372K | – | 9858 |
|
|
2024
Q2 | $372K | Buy |
163,400
+20,300
| +14% | +$77.5K | ﹤0.01% | 3977 |
|
|
2024
Q1 | $618K | Buy |
143,100
+62,600
| +78% | +$218K | ﹤0.01% | 3625 |
|
|
2023
Q4 | $245K | Buy |
80,500
+41,000
| +104% | +$77K | ﹤0.01% | 4459 |
|
|
2023
Q3 | $56K | Sell |
39,500
-23,100
| -37% | -$44.7K | ﹤0.01% | 5711 |
|
|
2023
Q2 | $155K | Buy |
62,600
+32,500
| +108% | +$88.8K | ﹤0.01% | 4595 |
|
|
2023
Q1 | $80K | Buy |
30,100
+24,400
| +428% | +$117K | ﹤0.01% | 5416 |
|
|
2022
Q4 | $30K | Sell |
5,700
-1,000
| -15% | -$8.38K | ﹤0.01% | 6486 |
|
|
2022
Q3 | $83K | Sell |
6,700
-9,400
| -58% | -$107K | ﹤0.01% | 5779 |
|
|
2022
Q2 | $79K | Sell |
16,100
-33,200
| -67% | -$184K | ﹤0.01% | 5890 |
|
|
2022
Q1 | $374K | Buy |
49,300
+38,700
| +365% | +$367K | ﹤0.01% | 4242 |
|
|
2021
Q4 | $108K | Sell |
10,600
-20,800
| -66% | -$265K | ﹤0.01% | 6140 |
|
|
2021
Q3 | $705K | Hold |
31,400
| – | – | ﹤0.01% | 3594 |
|
|
2021
Q2 | $688K | Buy |
31,400
+31,155
| +12,716% | +$692K | ﹤0.01% | 3678 |
|
|
2021
Q1 | $589K | Buy |
245
+129
| +111% | +$3K | ﹤0.01% | 3139 |
|
|
2020
Q4 | $208K | Buy |
116
+114
| +5,700% | +$1.7K | ﹤0.01% | 4544 |
|
|
2020
Q3 | $2K | Sell |
2
-3
| -60% | -$50 | ﹤0.01% | 7477 |
|
|
2020
Q2 | $12K | Sell |
5
-23
| -82% | -$380 | ﹤0.01% | 6570 |
|
|
2020
Q1 | $30K | Buy |
28
+27
| +2,700% | +$504 | ﹤0.01% | 5634 |
|
|
2019
Q4 | $2K | Sell |
1
-3
| -75% | -$70 | ﹤0.01% | 7016 |
|
|
2019
Q3 | $9K | Sell |
4
-1
| -20% | -$32 | ﹤0.01% | 6330 |
|
|
2019
Q2 | $15K | Buy |
+5
| New | +$105 | ﹤0.01% | 5858 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$5K | – | 7988 |
|
|
2018
Q3 | $5K | Buy |
+1
| New | +$55 | ﹤0.01% | 6794 |
|
Simplex Trading's GTHX Position: Q1 2024 in Review
Simplex Trading sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 233,626 shares — an estimated $814K sold.
Simplex Trading first reported a position in GTHX in Q4 2018 and held it in 15 quarters. The position peaked at $712K in Q4 2023. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.
- Simplex Trading reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 233,626 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $814K.
- Simplex Trading first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2018 and held it in 15 quarters.
- Simplex Trading's G1 Therapeutics, Inc. Common Stock position peaked at $712K in Q4 2023.
- 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.